Kayawell
  • Switglim MV 2/0.3 Tablet

Switglim MV 2/0.3 Tablet

Picture of Switglim MV 2/0.3 Tablet
Switglim MV 2/0.3 Tablet is a combination of three antidiabetic medicines: Glimepiride, metformin and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor which prevents breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals.
Manufacturer: Akumentis Healthcare Ltd
Be the first to review this product
₹ 92.00 incl tax

Uses of Switglim MV Tablet ER

Switglim MV 2/0.3 Tablet is used in the treatment of type 2 diabetes.

Side effects of Switglim MV Tablet ER

Hypoglycemia (low blood sugar level), Nausea, Diarrhoea, Altered taste, Flatulence, Stomach pain, Headache, Skin rash, Upper respiratory tract infection.

How to use Switglim MV Tablet ER

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Switglim MV 2/0.3 Tablet is to be taken with food.
Switglim MV 2/0.3 Tablet may cause stomach upset if taken on empty stomach.
 
Warnings
Alcohol
Pregnancy
Lactation
Driving
Kidney
Liver.

We help patients connect with local pharmacy stores to fulfill their extensive medical needs. Thus, through our extensive portal and services we ensure you get access to the best and most genuine health products at reasonable price, with the highest savings in the shortest time possible.

KayaWell Icon

Information

Customer service

Powered by Kayawell
Copyright © 2024 Kayawell. All rights reserved.